OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.710
+0.050 (3.01%)
At close: Mar 9, 2026, 4:00 PM EDT
1.740
+0.030 (1.75%)
After-hours: Mar 9, 2026, 6:24 PM EDT
OKYO Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 88 | 43 | 50 | 34 | 109 | 74 | |
| Market Cap Growth | 137.47% | -12.97% | 47.06% | -68.99% | 46.71% | 1100.45% | |
| Enterprise Value | 81 | 42 | 48 | 33 | 103 | 67 | |
| Last Close Price | 1.66 | 1.27 | 1.49 | 1.32 | 5.14 | 7.15 | |
| PB Ratio | - | -7.77 | -8.42 | -16.40 | 36.84 | 13.94 | |
| P/TBV Ratio | - | - | - | - | 36.84 | 13.94 | |
| Debt / Equity Ratio | -0.05 | - | - | -1.08 | - | 0.02 | |
| Net Debt / Equity Ratio | 1.18 | 0.28 | 0.14 | 0.89 | -0.92 | -1.28 | |
| Net Debt / EBITDA Ratio | 0.65 | 0.22 | 0.05 | 0.14 | 0.44 | 2.01 | |
| Net Debt / FCF Ratio | 1.30 | 0.86 | 0.09 | 0.24 | 0.49 | 4.22 | |
| Quick Ratio | 0.53 | 0.37 | 0.19 | 0.69 | 2.65 | 4.08 | |
| Current Ratio | 0.58 | 0.40 | 0.21 | 0.72 | 3.17 | 4.09 | |
| Return on Equity (ROE) | - | - | - | -2968.51% | -131.55% | -130.13% | |
| Return on Assets (ROA) | -104.63% | -169.87% | -291.87% | -173.43% | -68.30% | -54.34% | |
| Return on Capital Employed (ROCE) | 183.10% | 127.80% | 267.90% | 642.30% | -211.00% | -62.60% | |
| Earnings Yield | -5.41% | -10.92% | -33.98% | -39.41% | -5.00% | -4.53% | |
| FCF Yield | -3.63% | -4.21% | -19.16% | -22.87% | -5.04% | -2.17% | |
| Buyback Yield / Dilution | -24.46% | -34.57% | -31.84% | -47.74% | -45.55% | -12.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.